(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
----------
Incanthera PLC - oncology firm focused on skin cancer - For six months to September 30, pretax loss widens to GBP582,000 from GBP471,000 a year before. Operating expenses rise 23% to GBP557,000 from GBP452,000. Does not post revenue. "We have made excellent progress in our discussions on the commercial rights for Sol during this period and have recently initiated commercial discussions with two further companies. The conclusion of the right deal for commercialisation of Sol is of paramount importance for the future success of the company and the whole team is engaged in delivering this for our shareholders. As we approach the end of 2021, I would like to thank our shareholders for their continuing support and our team for their hard work and dedication. We look forward to sharing further progress next year," company says. Sol is lead product and a topical product for the treatment of solar keratosis and the prevention of skin cancers.
----------
Botswana Diamonds PLC - exploration & project development company that holds licences in Botswana and South Africa - For 12 months ended June 30, pretax loss widens to GBP472,107 from GBP391,225. Administrative expenses rise 13% to GBP402,089 from GBP356,831. Does not post revenue. "The stock markets in recent years has been a hostile place for junior explorers including diamonds. Explorers need continued funding at least until a discovery goes into commercial production. A small group of investors have supported placings in BOD and I anticipate that this will continue. We have moved a very long way from a greenfield explorer. We now have a pipeline of projects at various stages of development," company says.
----------
Baronsmead Second Venture Trust PLC - investment firm based in London - Net asset value per share at September 30 rises to 29% year-on-year to 90.8 pence before dividend. Basic and diluted NAV per share rises 19% to 87.77p from 73.74p. Ups final dividend for the year to September 30 by 9.3% to 6.5p per share. "Despite the potential economic headwinds, the board continues to believe it is a good time to be investing in earlier stage, innovative and high growth potential businesses looking to take advantage of changes in consumer behaviour and the disruption of traditional supply chains being driven by technology," company says.
----------
By Greg Roxburgh; gregroxburgh@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
